4//SEC Filing
STROME MEZZANINE FUND, LP 4
Accession 0001713153-17-000003
CIK 0001101026other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:14 PM ET
Size
6.8 KB
Accession
0001713153-17-000003
Insider Transaction Report
Form 4
Zivo Bioscience, Inc.OTCQB:ZIVO
STROME MEZZANINE FUND, LP
10% Owner
Transactions
- Purchase
Common Stock Purchase Warrant
2017-11-17+16,666,667→ 16,666,667 totalExercise: $0.10From: 2017-11-17Exp: 2019-11-16→ Common Stock (16,666,667 underlying)
Footnotes (2)
- [F1]The Reporting Person entered into a Participation Agreement dated July 21, 2017 (the "Participation Agreement") with HEP Investments, LLC ("HEP") and Zivo Bioscience, Inc. ("Zivo"), as amended by the Amendment to Participation Agreement, Guaranty, Warrants and Amended and Restated Registration Rights Agreement dated November 15, 2017 (the "Amendment") under which the Reporting Person agreed to fund a portion of a Ninth Amended and Restated Secured Promissory Note made by Zivo in favor of HEP. Under the terms of the Participation Agreement, Zivo issues warrants to the Reporting Person upon certain funding benchmarks. A copy of the Participation Agreement was filed with the Reporting Person's Schedule 13D on July 31, 2017, and a copy of the Amendment was filed with the Reporting Person's Schedule 13D/A on November 21, 2017.
- [F2]Pursuant to Rule 16a-1(a)(4) of the Securities Exchange Act of 1934 (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.
Documents
Issuer
Zivo Bioscience, Inc.
CIK 0001101026
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001713153
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 6:14 PM ET
- Size
- 6.8 KB